Debut Plus

₹597

▼ -4.75 -0.79%

18 Jul 2026

NSE Listed

Lincoln Pharma Ltd. (LINCOLN)

Volume: 30,986Avg Vol 1W: 27,512.2Avg Vol 1M: 70,558.0552W Range:₹440₹770
NSE BSE www.lincolnpharma.com
Key Ratios
Checked 18h ago
Market Cap₹1,223 Cr
Current Price₹597
Previous Close₹601.75
High / Low (52w)₹770 / ₹440
Volume30,986
Avg Vol (1W)27,512.2
Avg Vol (1M)70,558.05
Stock P/E13.42
Book Value₹335.34
Dividend Yield—
ROE13%
ROA—
Revenue (TTM)₹646 Cr
Revenue Growth—
Profit Margin—
Total Debt₹0 Cr
Shares Outstanding—
Face Value₹10
EPS (TTM)₹41.11
P/B1.64
Debt / Equity0
50 DMA₹639.42
200 DMA₹569.67
Day change-0.79%
Price Chart
₹597▲ 5.41% · 1Y
₹758₹44446.8L
2025-07-17
2026-07-16

20-day avg volume: 71K shares

Pros
  • Company is almost debt-free.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹147 Cr₹161 Cr₹147 Cr₹168 Cr₹154 Cr₹163 Cr₹166 Cr₹187 Cr
EBITDA₹30 Cr₹35 Cr₹29 Cr₹17 Cr₹36 Cr₹29 Cr₹35 Cr₹17 Cr
Net Profit₹24 Cr₹26 Cr₹21 Cr₹12 Cr₹28 Cr₹20 Cr₹29 Cr₹12 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹366 Cr₹372 Cr₹398 Cr₹430 Cr₹482 Cr₹533 Cr₹615 Cr₹646 Cr
EBITDA₹52 Cr₹66 Cr₹69 Cr₹85 Cr₹97 Cr₹103 Cr₹124 Cr₹111 Cr
Net Profit₹35 Cr₹49 Cr₹51 Cr₹62 Cr₹69 Cr₹73 Cr₹93 Cr₹82 Cr
EPS17.3124.3625.7231.0834.6336.446.5841.11
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹347 Cr₹366 Cr₹389 Cr₹452 Cr₹534 Cr₹587 Cr₹700 Cr₹797 Cr
Total Liabilities₹123 Cr₹96 Cr₹76 Cr₹86 Cr₹101 Cr₹85 Cr₹107 Cr₹125 Cr
Equity₹225 Cr₹270 Cr₹313 Cr₹366 Cr₹433 Cr₹502 Cr₹593 Cr₹672 Cr
Total Debt————————
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹36 Cr₹70 Cr₹90 Cr₹89 Cr₹100 Cr₹69 Cr₹89 Cr₹119 Cr
Investing₹-12 Cr₹-18 Cr₹-31 Cr₹-64 Cr₹-78 Cr₹-37 Cr₹-57 Cr₹-79 Cr
Financing₹-11 Cr₹-36 Cr₹-38 Cr₹-6 Cr₹-3 Cr₹-5 Cr₹-5 Cr₹-6 Cr
Free Cash Flow₹36 Cr₹70 Cr₹90 Cr₹89 Cr₹100 Cr₹69 Cr₹89 Cr₹119 Cr
Shareholding
Promoter 49.78% Institutions 6.28% Public 43.94%
Efficiency & Working Capital
ROCE15.2%
Interest Coverage59.1
Dividend Payout—
Debtor Days97 d
Inventory Days46 d
Payable Days50 d
Cash Conversion Cycle94 d
Working Capital Days144 d
Shareholding Details

As of 2026-06-30

Promoter49.8%
FII4.6%
DII0.3%
Institutions4.9%
Public45.4%
Promoter Pledge0%
No. of Shareholders29,396
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters50.5%49.8%49.5%49.8%49.8%49.8%49.8%49.8%49.8%49.8%49.8%49.8%
FIIs2.6%3.2%3.9%3.9%5.2%5.2%5%5.1%4.7%4.7%5.2%4.6%
DIIs0%0%0.1%0%0%0%0%0%0%0%1.1%0.3%
Public46.9%47%46.5%46.2%45%45.1%45.2%45.1%45.5%45.5%43.9%45.4%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders28,67029,31631,37529,96731,33031,84831,86731,78432,37031,02628,30329,396
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Munjal Mahendrabhai PatelShareholding of Promoter and Promoter Group13.4%26,78,800
Ashish Rajanikant PatelShareholding of Promoter and Promoter Group10.6%21,22,902
Rajanikant Gulabdas PatelShareholding of Promoter and Promoter Group3.8%7,56,801
Mahendrabhai Gulabdas PatelShareholding of Promoter and Promoter Group3.4%6,75,000
Sunmed Corporation LlpShareholding of Promoter and Promoter Group2.5%5,00,000
Kailashben Mahendrabhai PatelShareholding of Promoter and Promoter Group2.4%4,80,000
Kishor M. ShahPublic Shareholding2.4%4,78,400
Downtown Travels LlpShareholding of Promoter and Promoter Group2.4%4,75,000
Hasmukhbhai Ishwarbhai PatelShareholding of Promoter and Promoter Group1.9%3,73,600
Anand Arvinbhai PatelShareholding of Promoter and Promoter Group1.7%3,32,000
Rimo Capital Fund LpPublic Shareholding1.4%2,70,450
Dheeraj Kumar LohiaPublic Shareholding1.2%2,48,816
Shivani Ashish PatelShareholding of Promoter and Promoter Group1%2,06,475
Mansi Munjal PatelShareholding of Promoter and Promoter Group1%2,00,000
Hansaben Arvindbhai PatelShareholding of Promoter and Promoter Group0.9%1,77,200
Patel Nishitkumar MaheshbhaiShareholding of Promoter and Promoter Group0.8%1,53,400
Dharmisthaben Bhagirath PatelShareholding of Promoter and Promoter Group0.6%1,24,459
Arvindbhai Gulabdas PatelShareholding of Promoter and Promoter Group0.6%1,11,000
Downtown Finance Pvt. Ltd.Shareholding of Promoter and Promoter Group0.5%1,06,000
Renukaben Maheshbhai PatelShareholding of Promoter and Promoter Group0.5%98,047
Jigar Hasmukhbhai PatelShareholding of Promoter and Promoter Group0.4%86,200
Patel Aniruddh HShareholding of Promoter and Promoter Group0.4%86,200
Mihir Viththalbhai PatelShareholding of Promoter and Promoter Group0.4%82,669
Dharmistaben Hasmukhbhai PatelShareholding of Promoter and Promoter Group0.3%65,003
Nidhi Mahendrabhai PatelShareholding of Promoter and Promoter Group0.3%54,000
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Munjal Mahendrabhai Patel00%2026-06-30
Ashish Rajanikant Patel00%2026-06-30
Rajanikant Gulabdas Patel00%2026-06-30
Mahendrabhai Gulabdas Patel00%2026-06-30
Kailashben Mahendrabhai Patel00%2026-06-30
Hasmukhbhai Ishwarbhai Patel00%2026-06-30
Anand Arvinbhai Patel00%2026-06-30
Shivani Ashish Patel00%2026-06-30
Mansi Munjal Patel00%2026-06-30
Hansaben Arvindbhai Patel00%2026-06-30
Patel Nishitkumar Maheshbhai00%2026-06-30
Dharmisthaben Bhagirath Patel00%2026-06-30
Board of Directors
NameDesignationYear
Kishorbhai M ShahChairman & Non Executive Dir.2025
Mahendra G PatelED / MD / Promoter2025
Hasmukhbhai I PatelWTD & Executive Director2025
Ashish Rajanikant PatelWTD & Executive Director2025
Munjal Mahendrabhai PatelWTD & Executive Director2025
Rajnikant G PatelNon-Exec & Non-Independent Dir2025
Saurin Jagdish Bhai ParikhIndependent Non Exe. Director2025
Nareshkumar Pirabhai SutharIndependent Non Exe. Director2025
Seema MehtaIndependent Non Exe. Director2025
Trusha ShahCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Pharmaceutical₹159 Cr75.9%
Chemicals₹50 Cr24.1%
Segments — Geography
RegionRevenueShare
Domestic₹236 Cr37.9%
Export₹387 Cr62.1%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10322020
Corporate Actions
TypeDateValueRemark
dividend2025-09-12₹1.8 (18%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202500041824
202500001717
2025000417
Insider / Designated-Person Trades

30 recent disclosure(s)

Munjal Mahendrabhai PatelAcquisition · 13,500
Munjal Mahendrabhai PatelAcquisition · 20,000
Munjal Mahendrabhai PatelAcquisition · 15,000
Patel Nishitkumar MaheshbhaiDisposal · 1,000
Patel Nishitkumar MaheshbhaiDisposal · 1,000
Renukaben Maheshbhai PatelDisposal · 1,500
Substantial Acquisitions (SAST)

25 disclosure(s)

Market04/06/2024 · 13,500
Market31/05/2024 - 03/06/2024 · 35,000
Market27/02/2024 · 1,000
Market26/02/2024 · 1,500
Market26/02/2024 · 1,000
Market23/02/2024 · 62,500
Company Information
Incorporated1995
ChairmanKishorbhai M Shah
AuditorSamir M Shah & Associates
Investor Email[email protected]; [email protected]
🌐 www.lincolnpharma.com ↗

📍 Lincoln House B/H Satyam Compe, Science City Road Sola, Ahmedabad, Gujarat, 380060

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Libas Consu Products Ltd.Liberty Shoes Ltd.LIC Housing Finance Ltd.Life Insura Corp Of IndiaLikhitha Infrastruc Ltd.Linc LimitedLinde India LimitedLiotech Industries LimitedLloyds Luxuries LimitedLloyds Engg Work LimitedLloyds Enterprises Ltd.Lloyds Metals N Energy LimitedAll “L” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search